logo
Plus   Neg
Share
Email

4D Collaborates With Merck To Develop Live Biotherapeutics For Vaccines

4D pharma plc (DDDD.L) said it reached a research collaboration and option to license agreement with Merck & Co., Inc. (MRK) to discover and develop Live Biotherapeutics for vaccines.

As per the terms of the deal, 4D's proprietary MicroRx platform will be paired with Merck's expertise in the development and commercialisation of novel vaccines, to discover and develop Live Biotherapeutics as vaccines in up to three undisclosed indications.

4D has the right to cause Merck to purchase $5 million in ordinary shares in 4D during the first 12 months of the collaboration.

In addition to an upfront cash payment, for each indication, 4D will be eligible to receive up to $347.5 million in option exercise and development and regulatory milestone payments, plus tiered royalties on annual net sales of any licensed products derived from the collaboration.

Merck will be responsible for development, manufacturing and commercialisation following the exercise of any of its exclusive options.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The Federal Trade Commission (FTC) is in the process of sending out refund checks to consumers who were allegedly misled by Office Depot, Inc. and its software provider Support.com, Inc., into buying computer repair products and services. Out of $34 million, being the total amount of checks, Office Depot paid $25 million and Support.com paid $10 million as part of 2019 settlement. Gap Inc. partnered with fashion resale platform thredUP to facilitate the exchange of secondhand cloths. The retailer in a blog post said its customers can bring secondhand clothes in exchange for shopping credit that can be redeemed at Gap, Banana Republic, Athleta, or Janie and Jack. Customers who redeem their credits at Gap brands will receive an additional 15 percent payout bonus. Coca-Cola Co. (KO) on Friday reaffirmed its guidance for the full-year 2020 and provided an update on the expected impact from COVID-19 on first quarter 2020 results, ahead of its presentation at the Consumer Analyst Group of New York (CAGNY) Conference. For fiscal 2020, the company continues to project...
Follow RTT
>